Your browser doesn't support javascript.
loading
Hormone therapy and its risk after gynecological malignancy operation / 中国实用妇科与产科杂志
Chinese Journal of Practical Gynecology and Obstetrics ; (12): 651-654, 2019.
Artigo em Chinês | WPRIM | ID: wpr-816231
ABSTRACT
With the improvement of therapy,the survival time of patients with gynecological malignant tumor is prolonged,so improving their quality of life has become a new challenge for doctors.These patients may be in perimenopause themselves,or be in artificial menopause due to tumor treatment,and their climacteric symptoms are more obvious than those in natural menopause.Whether hormone therapy could be used to relieve the climacteric symptoms in these patients is still controversial at present.Clinicians should give individualized hormone therapy cautiously on the basis of patients' informed consent.

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Tipo de estudo: Estudo de etiologia Idioma: Chinês Revista: Chinese Journal of Practical Gynecology and Obstetrics Ano de publicação: 2019 Tipo de documento: Artigo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Tipo de estudo: Estudo de etiologia Idioma: Chinês Revista: Chinese Journal of Practical Gynecology and Obstetrics Ano de publicação: 2019 Tipo de documento: Artigo